PMC6260759_01
vWF and Factor VIII response to intravenous immunoglobulin (IVIg) therapy
12959_2018_184_Fig1_HTML.jpg
PMC6260759_01_12959_2018_184_Fig1_HTML.jpg
Fig1
This regimen resulted in a clinical response with cessation of the bleeding and partial transient recovery of the vWF and Factor VIII levels (Fig. 1).